首页> 外文OA文献 >Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli
【2h】

Development of an antibiotic-free plasmid selection system based on glycine auxotrophy for recombinant protein overproduction in Escherichia coli

机译:开发基于甘氨酸营养缺陷型的无抗生素质粒选择系统,用于大肠杆菌中重组蛋白的过量生产

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

First paragraph (this article has no abstract) Antibiotics and antibiotics resistance genes have been traditionally used for the selection and maintenance of recombinant plasmids in hosts such as E. coli. Although a powerful selection tool, their use has been considered unacceptable in many areas of biotechnology by regulatory authorities. Indeed, there is much international scientific and regulatory focus on this issue [1]. For instance, the use of selection markers that confer resistance to antibiotics in vaccine plasmids may introduce the risk of transforming the patient's microflora and spread resistance genes. Moreover, in recombinant protein production for therapeutic use, the antibiotic must be eliminated from the final product. Another problem arises from the potential loss of selective pressure as a result of antibiotic degradation i.e. ampicillin can be degraded by β-lactamases in less than 30 minutes in high cell density cultures [2].
机译:第一段(本文没有摘要)传统上,抗生素和抗生素抗性基因已用于选择和维持宿主(如大肠杆菌)中的重组质粒。尽管功能强大的选择工具,但监管机构认为在生物技术的许多领域中,它们的使用是不可接受的。确实,对此问题有很多国际科学和法规关注[1]。例如,在疫苗质粒中使用赋予抗生素抗性的选择标记可能会导致转化患者微生物区系和传播抗性基因的风险。此外,在用于治疗用途的重组蛋白生产中,必须从最终产品中消除抗生素。另一个问题是由于抗生素降解而导致选择性压力的潜在丧失,即在高细胞密度培养物中,氨苄青霉素可在不到30分钟的时间内被β-内酰胺酶降解[2]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号